DOI QR코드

DOI QR Code

Effect on Smoking Quit Rate of Telling Smokers their Health Risk Appraisal in Terms of Health Age: A Randomized Control Trial

  • Paek, Yu-Jin (Department of Family Medicine, Health Promotion Center, Hallym University Sacred Heart Hospital) ;
  • Lee, Sungkyu (Graduate School of Public Health, Yonsei University) ;
  • Kim, Yun-Hee (Department of Nursing, Pukyong National University) ;
  • Lee, Kang-Sook (Department of Preventive Medicine and Health Promotion Medicine, The Catholic University of Korea) ;
  • Yim, Hyeon-Woo (Department of Preventive Medicine and Health Promotion Medicine, The Catholic University of Korea) ;
  • Kim, Myung-Shig (Department of Counseling Psychology, Jeonju University) ;
  • Kim, Cheol-Hwan (Inje Institute of Advanced Studies/Smoking Cessation Clinic of Seoul Paik Hospital) ;
  • Jeung, Ok (Department of Counseling Psychology, Seoul Cyber University)
  • Published : 2014.06.30

Abstract

Background: We evaluated whether providing health risk appraisal for Koreans (KHRA) in terms of 'health age' during smoking cessation program would effectively help smokers quit smoking or not. Materials and Methods: A total of 332 male smokers aged between 30-65 years old, registered for a smoking cessation program in a public health center in a city, were recruited and underwent a baseline survey from January 2010 to February 2011. They were then prospectively randomized to a conventional counseling group (n=165) or a KHRA group (n=167), and received conventional counseling or KHRA-based counseling for six months. Abstinence rates were identified through carbon monoxide measurement (at the $4^{th}$ and $24^{th}$ weeks) or urinary cotinine level (at the $12^th$ week). Results: The abstinence rate confirmed by exhaled carbon monoxide was significantly higher in the KHRA group (61.1%) than the control group (49.1%) at the $4^{th}$ week (absolute difference 12.0%, 95% CI: 1.4%-22.6%). However, there was no difference in abstinence rates between the two groups at the 12th and 24th weeks. The predicting factors of 24 week's smoking cessation success were age, older than 50 years old (OR 2.02, 95% CI: 1.16-3.52), lower Fagerstr$\ddot{o}$m Test for Nicotine Dependence score less than 4 (OR 1.84, 95% CI: 1.03-3.29), and higher Self Efficacy/Temptation score (OR 1.79, 95% CI: 1.05-3.06). Conclusions: Smoking cessation counseling with KHRA could be effective compared to conventional counseling in the short period of smoking cessation. Further study is needed to evaluate the long-term efficacy of KHRA in tobacco dependence treatment and to establish the indication and target population of this tool.

Keywords

References

  1. Alexander G (2003). Health risk appraisal. Int Electron J Health Educ, 3, 133-7.
  2. Audrain J, Boyd NR, Roth J, et al (1997). Genetic susceptibility testing in smoking-cessation treatment: one-year outcomes of a randomized trial. J Addict Behav, 22, 741-51. https://doi.org/10.1016/S0306-4603(97)00060-9
  3. Bovet P, Perret F, Cornuz J, et al (2002). Improved smoking cessation in smokers given ultrasound photographs of their own atherosclerotic plaques. Prev Med, 34, 215-20. https://doi.org/10.1006/pmed.2001.0976
  4. Buffels J, Degryse J, Decramer M, et al (2005). Can spirometry improve the success rate of smoking cessation in general practice. Eur Respir J, 26, 670.
  5. Buffels J, Degryse J, Decramer M, et al (2006). Spirometry and smoking cessation advice in general practice: a randomised clinical trial. Respir Med, 100, 2012-7. https://doi.org/10.1016/j.rmed.2006.02.014
  6. Doll R, Peto R, Wheatley K, et al (1994). Mortality in relation to smoking: 40 years' observations on male british doctors. BMJ, 309, 901-11. https://doi.org/10.1136/bmj.309.6959.901
  7. Fletcher DJ, Smith GL (1986). Health-risk appraisal. helping patients predict and prevent health problems. Postgrad Med, 80, 69-71. https://doi.org/10.1080/00325481.1986.11699632
  8. Ito H, Matsuo K, Wakai K, et al (2006). An intervention study of smoking cessation with feedback on genetic cancer susceptibility in Japan. Prev Med, 42, 102-8. https://doi.org/10.1016/j.ypmed.2005.10.006
  9. Jayakirshnan R, Uutela A, Mathew A, et al (2013) Smoking cessation intervention in rural Kerala, India; findings of a randomised controlled trial. Asian Pac J Cancer Prev, 14, 6797-802. https://doi.org/10.7314/APJCP.2013.14.11.6797
  10. Karimy M, Niknami S, Heidarina AR, et al (2013). Refusal self efficacy, self esteem, smoking refusal skills and water pipe(hookah) smoking among Iranian male adoescents. Asian Pac J Cancer Prev, 14, 7283-8 https://doi.org/10.7314/APJCP.2013.14.12.7283
  11. Kim J (2004). The predictive accuracy of health risk appraisal in Korean males: using national health insuarance incorporation program. MPH Thesis, Seoul National University.
  12. Lerman C, Gold K, Audrain J, et al (1997). Incorporating biomarkers of exposure and genetic susceptibility into smoking cessation treatment: effects on smoking-related cognitions, emotions, and behavior change. Health Psychol, 16, 87. https://doi.org/10.1037/0278-6133.16.1.87
  13. Lin M, Huang S, Shih W, et al (2013). Effects of an anti-smoking program to prevent lung cancer among urban aboriginals in Taiwan. Asian Pac J Cancer Prev, 14, 6451-7. https://doi.org/10.7314/APJCP.2013.14.11.6451
  14. Martin-Lujan F, Pinol-Moreso JL, Martin-Vergara N, et al (2011). Effectiveness of a structured motivational intervention including smoking cessation advice and spirometry information in the primary care setting: the ESPITAP study. BMC Public Health, 11, 859. https://doi.org/10.1186/1471-2458-11-859
  15. Oh J, Lim MK, Yun EH, et al (2013). Cost and effectiveness of the nationwide government-supported smoking cessation clinics in the republic of Korea. Tob Control, 22, 73-7. https://doi.org/10.1136/tobaccocontrol-2011-050110
  16. Park J (2007). The development and validation of health risk appraisal (HRA) in Korean men and women. PhD Thesis, Seoul National University.
  17. Parkes G, Greenhalgh T, Griffin M, et al (2008). Effect on smoking quit rate of telling patients their lung age: the step2quit randomised controlled trial. BMJ, 336, 598-600. https://doi.org/10.1136/bmj.39503.582396.25
  18. Risser NL, Belcher DW (1990). Adding spirometry, carbon monoxide, and pulmonary symptom results to smoking cessation counseling. J Gen Intern Med, 5, 16-22. https://doi.org/10.1007/BF02602303
  19. Robbins L, Blankenbaker R (1982). Prospective Medicine And The Health Hazard Appraisal. Norwalk: Appleton-Century-Crofts.
  20. Robbins L, Hall J (1970). How To Practice Prospective Medicine. Methodist Hospital of Indiana: Indianappolis.
  21. Rodondi N, Collet T, Nanchen D, et al (2012). Impact of carotid plaque screening on smoking cessation and other cardiovascular risk factors: a randomized controlled trial. Arch Intern Med, 172, 344. https://doi.org/10.1001/archinternmed.2011.1326
  22. Sadusk Jr JF, Robbins LC (1968). Proposal for health-hazard appraisal in comprehensive health care. JAMA, 203, 1108-12. https://doi.org/10.1001/jama.1968.03140130020004
  23. Stead LF, Perera R, Bullen C, et al (2008). Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev, 1, CD000146.
  24. Wilt TJ, Niewoehner D, Kane RL, et al (2007). Spirometry as a motivational tool to improve smoking cessation rates: a systematic review of the literature. Nicotine Tob Res, 9, 21-32. https://doi.org/10.1080/14622200601078509

Cited by

  1. Intention to Quit Smoking among Intermediate and Secondary School Students in Saudi Arabia vol.16, pp.15, 2015, https://doi.org/10.7314/APJCP.2015.16.15.6741
  2. Impact of Smoking Cessation Training for Community Pharmacists in Indonesia vol.16, pp.8, 2015, https://doi.org/10.7314/APJCP.2015.16.8.3319
  3. Self-rated Subjective Health Status Is Strongly Associated with Sociodemographic Factors, Lifestyle, Nutrient Intakes, and Biochemical Indices, but Not Smoking Status: KNHANES 2007-2012 vol.30, pp.9, 2015, https://doi.org/10.3346/jkms.2015.30.9.1279